Details
Mission and objectives
The World Health Organization is a specialized agency of the United Nations Public Health Organization established in 1948. The objective of the World Health Organization shall be the attainment by all peoples of the highest possible level of health.
World Health Organization achieves its goals by performing its essential functions:
1. Take a leadership role in key health issues and create partnerships when joint action is needed;
2. Set research priorities and encourage the acquisition, application and dissemination of useful knowledge;
3. Setting standards and criteria and encouraging and monitoring them;
4. Develop ethical and evidence-based policies
5. Provide technical support, be an agent of change and build institutional capacity in a sustainable way;
6. Monitor health status and assess health trends.
World Health Organization achieves its goals by performing its essential functions:
1. Take a leadership role in key health issues and create partnerships when joint action is needed;
2. Set research priorities and encourage the acquisition, application and dissemination of useful knowledge;
3. Setting standards and criteria and encouraging and monitoring them;
4. Develop ethical and evidence-based policies
5. Provide technical support, be an agent of change and build institutional capacity in a sustainable way;
6. Monitor health status and assess health trends.
Context
Under the overall guidance of the Regional Adviser/Team Lead and in close collaboration with WHO headquarters (HQ), and country offices, the Technical Officer (Pharmacovigilance) will support Member States to implement the WHO Resolution on, and to operationalize the global smart pharmacovigilance strategy, including risk-based prioritization, reliance/work-sharing, integration in regulatory systems, and strengthened safety communication.
Task description
1. Facilitate regional uptake of global normative guidance and technical tools for smart pharmacovigilance and support measurement of uptake and impact of the global smart pharmacovigilance (PV) strategy (e.g., prioritized product lists, Adverse Events of Special Interest (AESI ) risk registers, reliance/work‑sharing, VigiBase use, PV maturity progress).
2. Support pharmacovigilance system assessments (e.g., World Health Organization (WHO) Global Benchmarking Tool – GBT) and assist countries in addressing and implementing PV components of Institutional Development Plans (IDPs).
3. Coordinate with WHO Collaborating Centres in the Region.
4. Support regional implementation of WHO-developed PV tools and protocols (e.g., reporting forms: VigiMobile, VigiFlow/VigiLyze, active surveillance protocol, background data on AESI, Risk Management Plan (RMP) assessment templates), particularly for the introduction of prequalified and new medicines/vaccines, and ensure relevant data are shared with WHO Headquarters (HQ ) advisory committees.
5. Provide feedback to WHO Headquarters (HQ ) on the feasibility and contextualization of global PV metrics; coordinate and support pilots in selected countries and scale‑up as it relates to the WHO Africa region.
6. Strengthen regional PV collaboration, including information‑sharing mechanisms, reliance and work‑sharing arrangements, and joint signal reviews with National Regulatory Authorities (NRAs ) and programmes.
7. Support countries in prioritizing risk‑based PV actions and strengthen collaboration of PV within immunization and public health programmes to reduce data silos, align case definitions, investigations, and risk communication.
8. Advocate for the Vaccine Safety Net (VSN) and promote trustworthy communication channels.
9. Represent the Region in Programme for International Drug Monitoring (PIDM ) forums (e.g., annual meeting) and support the organization of regional PIDM activities when hosted by a Member State.
10. Provide technical assistance to countries to detect and act on local signals and convene regional network meetings on priority topics.
11. Support countries to improve reporting and build capacity for causality assessment and data analysis for safety signals and reporting.
12. Advance the use of artificial intelligence (AI ) in pharmacovigilance in the region.
13. Conduct surveys and landscape analysis of the uptake of the Smart Strategy.
14. Provide support in coordinating and engaging relevant technical experts, as required, for the effective implementation of planned PV activities in the region
2. Support pharmacovigilance system assessments (e.g., World Health Organization (WHO) Global Benchmarking Tool – GBT) and assist countries in addressing and implementing PV components of Institutional Development Plans (IDPs).
3. Coordinate with WHO Collaborating Centres in the Region.
4. Support regional implementation of WHO-developed PV tools and protocols (e.g., reporting forms: VigiMobile, VigiFlow/VigiLyze, active surveillance protocol, background data on AESI, Risk Management Plan (RMP) assessment templates), particularly for the introduction of prequalified and new medicines/vaccines, and ensure relevant data are shared with WHO Headquarters (HQ ) advisory committees.
5. Provide feedback to WHO Headquarters (HQ ) on the feasibility and contextualization of global PV metrics; coordinate and support pilots in selected countries and scale‑up as it relates to the WHO Africa region.
6. Strengthen regional PV collaboration, including information‑sharing mechanisms, reliance and work‑sharing arrangements, and joint signal reviews with National Regulatory Authorities (NRAs ) and programmes.
7. Support countries in prioritizing risk‑based PV actions and strengthen collaboration of PV within immunization and public health programmes to reduce data silos, align case definitions, investigations, and risk communication.
8. Advocate for the Vaccine Safety Net (VSN) and promote trustworthy communication channels.
9. Represent the Region in Programme for International Drug Monitoring (PIDM ) forums (e.g., annual meeting) and support the organization of regional PIDM activities when hosted by a Member State.
10. Provide technical assistance to countries to detect and act on local signals and convene regional network meetings on priority topics.
11. Support countries to improve reporting and build capacity for causality assessment and data analysis for safety signals and reporting.
12. Advance the use of artificial intelligence (AI ) in pharmacovigilance in the region.
13. Conduct surveys and landscape analysis of the uptake of the Smart Strategy.
14. Provide support in coordinating and engaging relevant technical experts, as required, for the effective implementation of planned PV activities in the region
At Impactpool we do our best to provide you the most accurate info, but closing dates may be wrong on our site. Please check on the recruiting organization's page for the exact info. Candidates are responsible for complying with deadlines and are encouraged to submit applications well ahead.
Before applying, please make sure that you have read the requirements for the position and that you qualify. Applications from non-qualifying applicants will most likely be discarded by the recruiting manager.